# SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

> **NCT00026377** · PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 3 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** flutamide
- **DRUG:** goserelin acetate
- **DRUG:** leuprolide acetate
- **DRUG:** SU5416
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00026377
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2002-03
- **Final completion:** 2003-04
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2013-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00026377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00026377, "SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00026377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*